科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
专利缴费
专利查询
未登录
返回
期刊详情
Journal of Dermatological Treatment
IF
3.9
论文数
353
被引数
5093
相关解读
0
订阅
期刊论文
353
相关解读
0
期刊论文
353
发表时间
发表时间
IF
被引数
Balancing safety and efficacy in photodynamic therapy for facial port-wine stains in children aged 2-7 years: a prospective controlled study of light-intensity optimization
针对2-7岁儿童面部葡萄酒色斑的光动力疗法中安全性与有效性的平衡:一项关于光强度优化的前瞻性对照研究
Journal of Dermatological Treatment
IF
3.9
2026-10-23
0
OA
AI
Jiawen Qin; Xiaoxi Lin; Yue Han; Yize Zhang; Jingyan Huang; Cara Kou Yan; Xiaolin Zhang; Gang Ma; Hanru Ying
分享
收藏
Do genetic deficiency states predict the effect of pharmacologic target blockade?
遗传缺陷状态能否预测药理靶点阻断的效果?
Journal of Dermatological Treatment
IF
3.9
2026-10-07
0
OA
AI
Brett R. Shaffer; Yash C. Jani; Steven R. Feldman
分享
收藏
Randomized evidence breadth and comparative maturity of systemic targeted therapies for prurigo nodularis: a time-aligned systematic review and network meta-analysis
随机化证据广度及系统性靶向疗法治疗结节性痒疹的比较成熟度:一项时间对齐的系统评价和网络Meta分析
Journal of Dermatological Treatment
IF
3.9
2026-10-07
0
OA
AI
Yanchen Liu; Haoran Hu; Linfeng Li
分享
收藏
Association of a Han Chinese urticaria-derived polygenic risk score with chronic spontaneous urticaria susceptibility and advanced systemic treatment use
汉族荨麻疹衍生多基因风险评分与慢性自发性荨麻疹易感性和高级系统性治疗使用的关系
Journal of Dermatological Treatment
IF
3.9
2026-09-30
0
OA
AI
Yun-Wen Chen; Yi-Ming Chen; Kuo-Tung Tang; Heh-Shiang Sheu; Wen-Nan Huang; I-Chieh Chen
分享
收藏
Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework
我们应该监测接受系统性皮肤科治疗的患者的精神不良影响吗?:一个拟定的临床框架
Journal of Dermatological Treatment
IF
3.9
2026-09-29
0
OA
AI
Nina Modanlo; Mohnish Alishala; Hira Ghani; Sasha Ghofrani; Mohammad Jafferany
分享
收藏
Mechanism-based reporting patterns of infection-related adverse events with systemic psoriasis therapies in FAERS
基于机制的感染相关不良事件报告模式:系统性银屑病疗法在FAERS中的表现
Journal of Dermatological Treatment
IF
3.9
2026-09-29
0
OA
AI
Shinwon Hwang; Yerim Kwak; Yeon Woo Jung; Se Yong Jung; Jae Il Shin; Tae-Gyun Kim
分享
收藏
Commentary on benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the heads up trial
对dupilumab和upadacitinib获益-风险特征比较的评论:heads up试验的结构化获益-风险评估
Journal of Dermatological Treatment
IF
3.9
2026-09-28
0
OA
AI
Ercan Yılmaz; Nezihe Koker Özer; Erdem Topal
分享
收藏
Surgery without postoperative adjuvant therapy for dissecting cellulitis of the scalp: a retrospective study of a selected cohort
手术治疗头皮剥脱性蜂窝织炎,无需术后辅助治疗:一项对选定队列的回顾性研究
Journal of Dermatological Treatment
IF
3.9
2026-09-28
0
OA
AI
Junyou Zheng; Rundong Zhang; Ke Zhang; Qian Zhang; Yan Wang; Wenbo Bu; Binbin Hou
分享
收藏
Treatment response to systemic therapies in pediatric-onset versus adult-onset psoriasis: a longitudinal real-world study
儿童期与成年期发病银屑病对系统性治疗反应的比较:一项纵向真实世界研究
Journal of Dermatological Treatment
IF
3.9
2026-09-23
0
OA
AI
Siqi Li; Yuxiong Jiang; Didaer Muheyati; Yuanwenke Zhang; Min Dai; Qian Yu; Dawei Huang; Yu Wang; Qian Yu; Yuling Shi
分享
收藏
Commentary on treatment outcomes and influencing factors of photodynamic therapy in extramammary Paget’s disease: a retrospective analysis of 31 cases
光动力疗法治疗外阴Paget病治疗结局及影响因素的评述:31例病例的回顾性分析
Journal of Dermatological Treatment
IF
3.9
2026-09-12
0
OA
AI
Ercan Yılmaz; Nezihe Köker özer; Erdem Topal
分享
收藏
The emerging applications of JAK inhibitors in dermatology – a systematic review
JAK抑制剂在皮肤病学中的新兴应用——系统综述
Journal of Dermatological Treatment
IF
3.9
2026-09-11
0
OA
AI
Khalid M. A. Ahmed; Alaa I. Alnajdawi; Nithikka Senthil Kumar; Syeda Mashala Jan; Katharine L. Warburton
分享
收藏
Use of topical treatment among Swedish children with eczema during the first 18 months of life
瑞典婴幼儿湿疹患者前18个月外用药物治疗的使用情况
Journal of Dermatological Treatment
IF
3.9
2026-09-10
0
OA
AI
Maja af Klinteberg; Bo Glas; Richard Lundberg-Ulfsdotter; Magnus Domellöf; Christina E. West
分享
收藏
Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States
美国中度特应性皮炎患者使用鲁索利替尼乳膏与系统性疗法治疗的真实世界临床经验
Journal of Dermatological Treatment
IF
3.9
2026-09-07
0
OA
AI
Jinan Liu; Oliver Howell; James Piercy; Peter Anderson; Daniel Sturm
分享
收藏
Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update
2026年沙特阿拉伯中重度银屑病管理实用指南
Journal of Dermatological Treatment
IF
3.9
2026-09-07
0
OA
AI
Mohammed Ibrahim Fatani; Yousef Binamer; Dana Alessa; Hajer Y. Almudaiheem; Mohammed Abdulaziz Alajlan; Issam Hamadah; Bedor A. Al-Omari; Fahad Alzuriqan; Haifa F. Alotaibi; Waleed Alhazzani; Ahmed Aljedai; Maysa Tariq Eshmawi
分享
收藏
Real-world effectiveness of abrocitinib and upadacitinib in atopic dermatitis: a propensity-matched analysis
阿布罗西替平和乌帕西替平治疗特应性皮炎的真实世界有效性:一项倾向性匹配分析
Journal of Dermatological Treatment
IF
3.9
2026-09-07
0
OA
AI
Ruojun Wang; Zhihui Yang; Hang Li; Yang Wang
分享
收藏
Use of narrowband-UVB phototherapy as long-term treatment of urticaria pigmentosa: a case series
窄谱UVB光疗作为色素性荨麻疹的长期治疗:病例系列
Journal of Dermatological Treatment
IF
3.9
2026-09-02
0
OA
AI
Carli Tucci; Zasca-Aisha Ristianto; Elisabeth G. Richard; John G. Zampella
分享
收藏
Development of items to assess noticeability and sun sensitivity among patients with non-segmental vitiligo
非节段型白癜风患者注意力和光敏性的评估项目开发
Journal of Dermatological Treatment
IF
3.9
2026-09-02
0
OA
AI
David Rosmarin; Ahmed M. Soliman; Dana DiBenedetti; Amy Greenblatt; Rohini Sen; Stavonnie Patterson; Khaled Ezzedine
分享
收藏
Efficacy and safety of JAK inhibitors for vitiligo: an updated systematic review and meta-analysis of randomized controlled trials
白癜风中JAK抑制剂的疗效与安全性:一项更新的系统评价和随机对照试验的Meta分析
Journal of Dermatological Treatment
IF
3.9
2026-08-28
0
OA
AI
Ziyi Lin; Yi Chen; Jingpeng Chen; Yongxiang Long; Changxia Xiong; Xingwu Duan; Chunxiao Bai; Guangshan Chen
分享
收藏
Letter to editor regarding ‘Clinical predictors of early treatment response across systemic therapies in psoriasis: a prospective cohort study’
关于‘银屑病系统性治疗早期治疗反应的临床预测因素:一项前瞻性队列研究’致编辑的信
Journal of Dermatological Treatment
IF
3.9
2026-08-26
0
OA
AI
Deep Shikha; Sunita Sharma
分享
收藏
Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis: a plain language summary
度普利尤单抗治疗可改善6个月至11岁中重度特应性皮炎患儿的体征、症状和生活质量:一篇简明语言摘要
Journal of Dermatological Treatment
IF
3.9
2026-08-24
0
OA
AI
Elaine C. Siegfried; Michael J. Cork; Benjamin Lockshin; Norito Katoh; Wendy Smith Begolka; Ryan B. Thomas; Randy Prescilla
分享
收藏